Antigen Security announces partnership with Integrated Business Systems

Integrated Business Systems ("IBS") Launches Cyber-Insurance Savings Program with Antigen Security, Delivering Resilience by Design for Financial Services

TOTOWA, N.J.  , Oct. 14, 2025 /PRNewswire/ -- IBS today announced a new Cyber-Insurance Savings Program in partnership with Antigen Security, LLC ("Antigen"). Purpose-built for financial services, banking, accounting, payment processing, and specialized fintech, investment, and portfolio management firms, the program helps organizations align to insurer requirements, reduce the likelihood and impact of incidents, and qualify for meaningful premium savings. Organizations taking advantage of this program see an average of 30–60% savings on their cyber insurance as part of a standards-aligned, risk-informed cybersecurity strategy.

Built on proven frameworks - including CIS Controls, NIST CSF, and MITRE ATT&CK - the program operationalizes Resilience by Design: identify and prioritize risk, implement the right security controls, and document readiness so underwriting is straightforward and claims are successful when needed. IBS's partnership with Antigen designates IBS as a Risk Management Organization within Antigen's ecosystem, enabling access to carrier-approved technologies and streamlined insurance workflows from assessment through renewal.

WHAT CUSTOMERS CAN EXPECT

• Underwriting-Ready Controls: a clear pathway to meet or exceed carrier requirements with no guesswork. Applications take days rather than weeks.
• 30–60% Premium Savings (typical): risk-reducing controls and documented evidence translate into lower pricing and better terms.
• Lower Out-of-Pocket Costs: program design aims to minimize uncovered losses and incident-related expenses.
• Fewer Serious Incidents: proactive planning and continuous control validation reduce the likelihood and severity of breaches.

TAILORED FOR FINANCIAL SERVICES & ADJACENT SECTORS

• Banking & Credit Unions: protect customer data and payment systems; support GLBA and examiner expectations.
• Accounting & Advisory Firms: safeguard PII/financial records; align with client assurance and audit requirements.
• Payment Processors & ISOs: reduce PCI DSS exposure and lateral-movement risk across multi-tenant environments.
• Fintech & Payment Platforms: secure cloud workloads, APIs, and third-party integrations central to modern services.
• Investment & Portfolio Management: protect trading systems, client communications, and sensitive portfolio data.

EXECUTIVE PERSPECTIVES
"Financial institutions run on trust and time-to-resolution," said Michael Mullin, President, IBS. "By pairing IBS's sector-specific expertise with Antigen, our clients can demonstrate readiness to underwriters, cut friction in renewals, and turn better security outcomes into lower premiums - Resilience by Design."

"IBS understands the regulatory realities and multifaceted risks of banks, processors, and advisory firms," added Steven Legg, Co-Founder & CEO, Antigen Security. "Together we streamline underwriting and improve claim outcomes while lowering total cost of risk."

GET STARTED
Current customers, prospective customers, channel partners, and referrers: request a savings assessment and underwriting-readiness review
https://www.ibsre.com/north-jersey-cyber-insurance

ABOUT IBS
IBS delivers managed IT and security services tailored to financial services, including banking, accounting, commercial real estate, payment processing, fintech, and investment/portfolio management. IBS helps regulated and security-sensitive organizations improve reliability, meet compliance obligations, and operate with confidence. Learn more at ibsre.com.

ABOUT ANTIGEN SECURITY, LLC
Antigen Security is a technology services distributor dedicated to enabling superior cyber-liability insurance outcomes. By aligning advanced technology solutions with underwriting standards, Antigen helps organizations mitigate risk, reduce costs, and streamline compliance. Learn more at antigensecurity.com.

MEDIA CONTACT
IBS — Account Team
973-575-4950 • [email protected] • https://www.ibsre.com/

SOURCE Antigen Security LLC